A genetic variant in miRNA binding site of glutamate receptor 4, metabotropic (GRM4) is associated with increased risk of major depressive disorder

Journal of Affective Disorders

Volumn 208, Issue , 2017, Pages 218-222

  Dadkhah, Tahereh ^a   Rahimi Aliabadi, Simin ^b   Jamshidi, Javad ^c   Ghaedi, Hamid ^b   Taghavi, Shaghyegh ^b   Shokraeian, Parasto ^d   Akhavan Niaki, Haleh ^a   Tafakhori, Abbas ^e   Ohadi, Mina ^f   Darvish, Hossein ^b  

^a BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c FASA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

^e IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f UNIVERSITY OF SOCIAL WELFARE AND REHABILITATION SCIENCES   (Iran)

Author keywords

Depression; GRM4; MiR 1202; Single nucleotide polymorphism

Indexed keywords

METABOTROPIC RECEPTOR 4; MICRORNA; MICRORNA 1202; UNCLASSIFIED DRUG; METABOTROPIC RECEPTOR;

3' UNTRANSLATED REGION; ADULT; ARTICLE; BINDING SITE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; SINGLE NUCLEOTIDE POLYMORPHISM; BRAIN; GENETICS; METABOLISM; RISK;

ADULT; BINDING SITES; BRAIN; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, METABOTROPIC GLUTAMATE; RISK;

EID: 84992490345     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2016.10.008     Document Type: Article

References (26)

1. ®). 2013, American Psychiatric Pub.
2. Bartel, D.P., MicroRNAs: target recognition and regulatory functions. Cell 136 (2009), 215–233.
3. Bespalov, A.Y., van Gaalen, M.M., Sukhotina, I.A., Wicke, K., Mezler, M., Schoemaker, H., Gross, G., Behavioral characterization of the mGlu group II/III receptor antagonist, LY-341495, in animal models of anxiety and depression. Eur. J. Pharmacol. 592 (2008), 96–102.
4. Ferraguti, F., Shigemoto, R., Metabotropic glutamate receptors. Cell Tissue Res. 326 (2006), 483–504.
5. Filipowicz, W., Bhattacharyya, S.N., Sonenberg, N., Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat. Rev. Genet. 9 (2008), 102–114.
6. Friedman, R.C., Farh, K.K., Burge, C.B., Bartel, D.P., Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19 (2009), 92–105.
7. Gonzalez, J.R., Armengol, L., Sole, X., Guino, E., Mercader, J.M., Estivill, X., Moreno, V., SNPassoc: an R package to perform whole genome association studies. Bioinformatics 23 (2007), 644–645.
8. Haghnejad, L., Emamalizadeh, B., Jamshidi, J., Bidoki, A.Z., Ghaedi, H., Ahmadi, E., Abdollahi, S., Shahmohammadibeni, N., Taghavi, S., Fazeli, A., Motallebi, M., Zarneh, A.E., Mohammadihosseinabad, S., Abbaszadegan, M.R., Torkamandi, S., Gavenaroudi, M.A., Pedram, N., Shahidi, G.A., Tafakhori, A., Darvish, H., Movafagh, A., Variation in the miRNA-433 binding site of FGF20 is a risk factor for Parkinson's disease in Iranian population. J. Neurol. Sci. 355 (2015), 72–74.
9. Hamosh, A., Scott, A.F., Amberger, J.S., Bocchini, C.A., McKusick, V.A., Online mendelian inheritance in man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res. 33 (2005), D514–517.
10. Hovelso, N., Sotty, F., Montezinho, L.P., Pinheiro, P.S., Herrik, K.F., Mork, A., Therapeutic potential of metabotropic glutamate receptor modulators. Curr. Neuropharmacol. 10 (2012), 12–48.
11. Lopez, J.P., Lim, R., Cruceanu, C., Crapper, L., Fasano, C., Labonte, B., Maussion, G., Yang, J.P., Yerko, V., Vigneault, E., El Mestikawy, S., Mechawar, N., Pavlidis, P., Turecki, G., miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment. Nat. Med. 20 (2014), 764–768.
12. Matrisciano, F., Storto, M., Ngomba, R.T., Cappuccio, I., Caricasole, A., Scaccianoce, S., Riozzi, B., Melchiorri, D., Nicoletti, F., Imipramine treatment up-regulates the expression and function of mGlu2/3 metabotropic glutamate receptors in the rat hippocampus. Neuropharmacology 42 (2002), 1008–1015.
13. Miller, S.A., Dykes, D.D., Polesky, H.F., A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res., 16, 1988, 1215.
14. Nakajima, Y., Iwakabe, H., Akazawa, C., Nawa, H., Shigemoto, R., Mizuno, N., Nakanishi, S., Molecular characterization of a novel retinal metabotropic glutamate receptor mGluR6 with a high agonist selectivity for L-2-amino-4-phosphonobutyrate. J. Biol. Chem. 268 (1993), 11868–11873.
15. Nicoletti, F., Bruno, V., Copani, A., Casabona, G., Knopfel, T., Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders?. Trends Neurosci. 19 (1996), 267–271.
16. Ohadi, M., Mirabzadeh, A., Esmaeilzadeh-Gharehdaghi, E., Rezazadeh, M., Hosseinkhanni, S., Oladnabi, M., Firouzabadi, S.G., Darvish, H., Novel evidence of the involvement of calreticulin in major psychiatric disorders. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 37 (2012), 276–281.
17. Pilc, A., Chaki, S., Nowak, G., Witkin, J.M., Mood disorders: regulation by metabotropic glutamate receptors. Biochem. Pharmacol. 75 (2008), 997–1006.
18. Pin, J.P., Duvoisin, R., The metabotropic glutamate receptors: structure and functions. Neuropharmacology 34 (1995), 1–26.
19. Podkowa, K., Rzezniczek, S., Marciniak, M., Acher, F., Pilc, A., Palucha-Poniewiera, A., A novel mGlu4 selective agonist LSP4-2022 increases behavioral despair in mouse models of antidepressant action. Neuropharmacology 97 (2015), 338–345.
20. Sanacora, G., Treccani, G., Popoli, M., Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 62 (2012), 63–77.
21. Sanacora, G., Gueorguieva, R., Epperson, C.N., Wu, Y.T., Appel, M., Rothman, D.L., Krystal, J.H., Mason, G.F., Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch. Gen. Psychiatry 61 (2004), 705–713.
22. Shi, J., Potash, J.B., Knowles, J.A., Weissman, M.M., Coryell, W., Scheftner, W.A., Lawson, W.B., DePaulo, J.R. Jr., Gejman, P.V., Sanders, A.R., Johnson, J.K., Adams, P., Chaudhury, S., Jancic, D., Evgrafov, O., Zvinyatskovskiy, A., Ertman, N., Gladis, M., Neimanas, K., Goodell, M., Hale, N., Ney, N., Verma, R., Mirel, D., Holmans, P., Levinson, D.F., Genome-wide association study of recurrent early-onset major depressive disorder. Mol. Psychiatry 16 (2011), 193–201.
23. Shukla, G.C., Singh, J., Barik, S., MicroRNAs: processing, maturation, target recognition and regulatory functions. Mol. Cell. Pharmacol. 3 (2011), 83–92.
24. Slawinska, A., Wieronska, J.M., Stachowicz, K., Palucha-Poniewiera, A., Uberti, M.A., Bacolod, M.A., Doller, D., Pilc, A., Anxiolytic- but not antidepressant-like activity of Lu AF21934, a novel, selective positive allosteric modulator of the mGlu(4) receptor. Neuropharmacology 66 (2013), 225–235.
25. Stachowicz, K., Klodzinska, A., Palucha-Poniewiera, A., Schann, S., Neuville, P., Pilc, A., The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems. Neuropharmacology 57 (2009), 227–234.
26. Wieronska, J.M., Klak, K., Palucha, A., Branski, P., Pilc, A., Citalopram influences mGlu7, but not mGlu4 receptors’ expression in the rat brain hippocampus and cortex. Brain Res. 1184 (2007), 88–95.